Broadpharm
Lonza

ASCO 2019

Daiichi Sankyo

Daiichi Sankyo to Presents ADC Pipeline Results

Peter Hofland
Data for several investigational compounds in the Daiichi Sankyo oncology pipeline will be presented at the upcoming annual meeting of the American Society of...

ASCO 2019 ADC Presentation Guide

Shaun Mehr
We have created the following guide to all presentations related to ADCs for the upcoming ASCO Annual Meeting 2019 taking place at the McCormick...
Featured Image: General views at the American Society for Clinical Oncology (ASCO) annual meeting. Courtesy: © ASCO/Max Gersh 2015. Used with permission.

Phase I Data for SAR408701 Supports Further Development in Lung Cancer

Featured Image: General views at the American Society for Clinical Oncology (ASCO) annual meeting. Courtesy: © ASCO/Max Gersh 2015. Used with permission.

New Data Demonstrates Potential for RemeGen’s RC48 in HER2+ Cancers

The sign I Amsterdam in front of rijksmuseum in Amsterdam, The Netherlands.

Sutro Presents Preliminary Results From Ongoing Phase I Study of STRO-001

PEER REVIEW

EDITORIAL

Understanding of the Underlying Mechanisms of Target-Independent Uptake and Toxicity

Peter Hofland
With 4 approved agents, antibody-drug conjugates or ADC have shown to be a very promising class of therapeutics. While the concept of ADCs is not...

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s...

Eric Rosenthal
In the aftermath of the fall of renowned breast cancer researcher Jose Baselga, MD, PhD, following revelations last month of his failure to disclose...

Benefitting from the Worldwide Supply Chain in the development of Antibody-drug...

Eric Rosenthal Reports | A Personal Remembrance of Two Giants of...

DOWNLOAD

ADC Review, Journal of Antibody-drug Conjugates
MADE POSSIBLE BY:
ADCBIO
Lonza
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policy makers.

News

Peer Review Articles

© 2013-2019 Sunvalley Communication, LLC. All Rights Reserved.